Thus, mice exposed to the CUMS protocol to elicit depression-like symptoms have altered expression of BA transporters and signaling mediators as well as neurotrophic factors in the hippocampus, and expression of a subset of these factors is restored to control levels following CSS treatment through a BA-mediated mechanism. Here, CFB is linked to depressive symptom measurement.